Eastern Bank’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,500
Closed -$59K 998
2024
Q4
$59K Hold
1,500
﹤0.01% 546
2024
Q3
$70.5K Buy
+1,500
New +$70.5K ﹤0.01% 508